Search

Your search keyword '"Horeweg, Nanda"' showing total 230 results

Search Constraints

Start Over You searched for: Author "Horeweg, Nanda" Remove constraint Author: "Horeweg, Nanda" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
230 results on '"Horeweg, Nanda"'

Search Results

1. Automated causal inference in application to randomized controlled clinical trials

3. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials

4. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation

5. Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE

6. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

7. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

8. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts

9. Prediction of recurrence risk in endometrial cancer with multimodal deep learning

10. Prognostic value of molecular classification in stage IV endometrial cancer

12. Accelerated Partial Breast Irradiation Using External Beam or Intraoperative Electron Radiation Therapy: 5-Year Oncological Outcomes of a Prospective Cohort Study

14. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

17. Age-Related Differences in Patient Preferences for Adjuvant Chemotherapy for High-Risk Endometrial Cancer

21. HECTOR: multimodal deep learning predicts recurrence risk in endometrial cancer.

22. SO019LBA/#875 Molecular features predicts outcomes in multicentric international study of chemoradiation and MRI based image guided brachytherapy for cervical cancer (EMBRACE): final analysis from bioembrace-I

23. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, -2 and -3 trials

26. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas

27. 3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer

29. QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

30. Abstract 5695: Deep learning risk prediction model of distant recurrence from H&E endometrial cancer slides

31. Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer

32. Supplementary Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer

34. Contributors

35. Screening for Lung Cancer

36. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.

37. MR‐based follow‐up after brachytherapy and proton beam therapy in uveal melanoma

38. EP116/#725 Low-grade p53abn endometrial carcinomas exist and are associated with a high risk of recurrence, even in low-stage disease

39. 2022-RA-925-ESGO Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1–3 trials and a prospective cohort study

40. 2022-RA-743-ESGO Improving risk stratification for cervical cancer in patients treated with concurrent chemoradiation and MRI-image guided adaptive brachytherapy in EMBRACE study: results from an international collaborative translational research study (BIOEMBRACE-I)

41. 2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers

42. 2022-RA-825-ESGO The impact of age on prognosis in women with endometrial cancer: a pooled analysis of the PORTEC-1, -2 and -3 randomised trials

43. 2022-RA-450-ESGO Benefit of adjuvant radiotherapy depends on molecular class of early-stage endometrial cancer

44. 2022-RA-809-ESGO Underlying causes and prognosis of mismatch repair deficiency in endometrial cancer other thanMLH1promoter hypermethylation

45. 2022-RA-648-ESGO Interpretable deep learning provides clues for prognostic refinement of the molecular endometrial cancer classification

46. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

50. Automated causal inference in application to randomized controlled clinical trials

Catalog

Books, media, physical & digital resources